Global Veterinary Therapeutics Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Veterinary Therapeutics Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Veterinary Therapeutics Market Overview:
Global Veterinary Therapeutics Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Veterinary Therapeutics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Veterinary Therapeutics Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Veterinary Therapeutics market in 2020.
Global Veterinary Therapeutics Market Segmentation
By Type, Veterinary Therapeutics market has been segmented into:
Anti-inflammatory
Parasiticides
Others
Market by Vaccines
Inactivated Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
By Application, Veterinary Therapeutics market has been segmented into:
Hospitals
Veterinary Clinics
Drug Stores
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Veterinary Therapeutics market are:
Bayer AG
Boehringer Ingelheim GmbH
Ceva Sante Animale
Dechra Pharmaceuticals PLC
Eli Lilly and Company (Elanco Animal Health)
Merck Animal Health
Sanofi (Merial Animal Health)
Virbac
Vetoquinol S.A.
Zoetis Inc.
1. Market Overview of Veterinary Therapeutics
1.1 Veterinary Therapeutics Market Overview
1.1.1 Veterinary Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Veterinary Therapeutics Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Veterinary Therapeutics Historic Market Size by Regions (2015-2020)
1.4 Veterinary Therapeutics Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Veterinary Therapeutics Sales Market by Type (2015-2026)
2.1 Global Veterinary Therapeutics Historic Market Size by Type (2015-2020)
2.2 Global Veterinary Therapeutics Forecasted Market Size by Type (2021-2026)
2.3 Anti-inflammatory
2.4 Parasiticides
2.5 Others
2.6 Market by Vaccines
2.7 Inactivated Vaccines
2.8 Live Attenuated Vaccines
2.9 Recombinant Vaccines
3. Covid-19 Impact Veterinary Therapeutics Sales Market by Application (2015-2026)
3.1 Global Veterinary Therapeutics Historic Market Size by Application (2015-2020)
3.2 Global Veterinary Therapeutics Forecasted Market Size by Application (2021-2026)
3.3 Hospitals
3.4 Veterinary Clinics
3.5 Drug Stores
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Veterinary Therapeutics Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Veterinary Therapeutics Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Veterinary Therapeutics Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Veterinary Therapeutics Business
5.1 Bayer AG
5.1.1 Bayer AG Company Profile
5.1.2 Bayer AG Veterinary Therapeutics Product Specification
5.1.3 Bayer AG Veterinary Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Boehringer Ingelheim GmbH
5.2.1 Boehringer Ingelheim GmbH Company Profile
5.2.2 Boehringer Ingelheim GmbH Veterinary Therapeutics Product Specification
5.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Ceva Sante Animale
5.3.1 Ceva Sante Animale Company Profile
5.3.2 Ceva Sante Animale Veterinary Therapeutics Product Specification
5.3.3 Ceva Sante Animale Veterinary Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Dechra Pharmaceuticals PLC
5.4.1 Dechra Pharmaceuticals PLC Company Profile
5.4.2 Dechra Pharmaceuticals PLC Veterinary Therapeutics Product Specification
5.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Eli Lilly and Company (Elanco Animal Health)
5.5.1 Eli Lilly and Company (Elanco Animal Health) Company Profile
5.5.2 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Product Specification
5.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Merck Animal Health
5.6.1 Merck Animal Health Company Profile
5.6.2 Merck Animal Health Veterinary Therapeutics Product Specification
5.6.3 Merck Animal Health Veterinary Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Sanofi (Merial Animal Health)
5.7.1 Sanofi (Merial Animal Health) Company Profile
5.7.2 Sanofi (Merial Animal Health) Veterinary Therapeutics Product Specification
5.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Virbac
5.8.1 Virbac Company Profile
5.8.2 Virbac Veterinary Therapeutics Product Specification
5.8.3 Virbac Veterinary Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Vetoquinol S.A.
5.9.1 Vetoquinol S.A. Company Profile
5.9.2 Vetoquinol S.A. Veterinary Therapeutics Product Specification
5.9.3 Vetoquinol S.A. Veterinary Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Zoetis Inc.
5.10.1 Zoetis Inc. Company Profile
5.10.2 Zoetis Inc. Veterinary Therapeutics Product Specification
5.10.3 Zoetis Inc. Veterinary Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Veterinary Therapeutics Market Size (2015-2026)
6.2 North America Veterinary Therapeutics Key Players in North America (2015-2020)
6.3 North America Veterinary Therapeutics Market Size by Type (2015-2020)
6.4 North America Veterinary Therapeutics Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Veterinary Therapeutics Market Size (2015-2026)
7.2 East Asia Veterinary Therapeutics Key Players in North America (2015-2020)
7.3 East Asia Veterinary Therapeutics Market Size by Type (2015-2020)
7.4 East Asia Veterinary Therapeutics Market Size by Application (2015-2020)
8. Europe
8.1 Europe Veterinary Therapeutics Market Size (2015-2026)
8.2 Europe Veterinary Therapeutics Key Players in North America (2015-2020)
8.3 Europe Veterinary Therapeutics Market Size by Type (2015-2020)
8.4 Europe Veterinary Therapeutics Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Veterinary Therapeutics Market Size (2015-2026)
9.2 South Asia Veterinary Therapeutics Key Players in North America (2015-2020)
9.3 South Asia Veterinary Therapeutics Market Size by Type (2015-2020)
9.4 South Asia Veterinary Therapeutics Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Veterinary Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Veterinary Therapeutics Key Players in North America (2015-2020)
10.3 Southeast Asia Veterinary Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Veterinary Therapeutics Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Veterinary Therapeutics Market Size (2015-2026)
11.2 Middle East Veterinary Therapeutics Key Players in North America (2015-2020)
11.3 Middle East Veterinary Therapeutics Market Size by Type (2015-2020)
11.4 Middle East Veterinary Therapeutics Market Size by Application (2015-2020)
12. Africa
12.1 Africa Veterinary Therapeutics Market Size (2015-2026)
12.2 Africa Veterinary Therapeutics Key Players in North America (2015-2020)
12.3 Africa Veterinary Therapeutics Market Size by Type (2015-2020)
12.4 Africa Veterinary Therapeutics Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Veterinary Therapeutics Market Size (2015-2026)
13.2 Oceania Veterinary Therapeutics Key Players in North America (2015-2020)
13.3 Oceania Veterinary Therapeutics Market Size by Type (2015-2020)
13.4 Oceania Veterinary Therapeutics Market Size by Application (2015-2020)
14. South America
14.1 South America Veterinary Therapeutics Market Size (2015-2026)
14.2 South America Veterinary Therapeutics Key Players in North America (2015-2020)
14.3 South America Veterinary Therapeutics Market Size by Type (2015-2020)
14.4 South America Veterinary Therapeutics Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Veterinary Therapeutics Market Size (2015-2026)
15.2 Rest of the World Veterinary Therapeutics Key Players in North America (2015-2020)
15.3 Rest of the World Veterinary Therapeutics Market Size by Type (2015-2020)
15.4 Rest of the World Veterinary Therapeutics Market Size by Application (2015-2020)
16 Veterinary Therapeutics Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Veterinary Therapeutics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|